miR-320a is an independent prognostic biomarker for invasive breast cancer - Wikidata - awgldk - TriplyDB

miR-320a is an independent prognostic biomarker for invasive breast cancer

miR-320a is an independent prognostic biomarker for invasive breast cancer

http://www.wikidata.org/entity/Q33967807

about

MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor.Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs.miR-29b is an indicator of prognosis in breast cancer patients.Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.MicroRNA-320a inhibits proliferation and invasion of breast cancer cells by targeting RAB11A CREB1-driven expression of miR-320a promotes mitophagy by down-regulating VDAC1 expression during serum starvation in cervical cancer cells MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin.Rab14 Suppression Mediated by MiR-320a Inhibits Cell Proliferation, Migration and Invasion in Breast Cancer.USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells.miR-320a serves as a negative regulator in the progression of gastric cancer by targeting RAB14.

P2860

Q33684987-47BDF495-39BC-4C29-BE44-736487A54F76 Q35768989-C36AEB7D-753E-4951-8256-1171D7E46078 Q35802764-ECEEE635-88CA-45B7-88A3-C659FCACCFCC Q36222283-245F99E2-4D96-44EF-B9B5-FBBA3DC7DD77 Q36250639-A2FDE62D-A531-4B5B-98BB-AC10F5F270D6 Q36544251-FA2CFD9B-0EA0-4CBE-BFEC-FA92B52CE1DC Q37437601-46EAAECA-7849-4592-8690-07A4D86C87D1 Q37514093-876F9A13-CC11-444A-B824-087744245EB3 Q41472080-D86FC109-9E6D-4DE8-BAB2-D644C40F49E2 Q42546919-C05B7503-DABC-4692-BF09-3EEF43327E5A

P2860

miR-320a is an independent prognostic biomarker for invasive breast cancer

http://www.wikidata.org/entity/Q33967807

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

miR-320a is an independent prognostic biomarker for invasive breast cancer

@ast

miR-320a is an independent prognostic biomarker for invasive breast cancer

@en

type

label

miR-320a is an independent prognostic biomarker for invasive breast cancer

@ast

miR-320a is an independent prognostic biomarker for invasive breast cancer

@en

prefLabel

miR-320a is an independent prognostic biomarker for invasive breast cancer

@ast

miR-320a is an independent prognostic biomarker for invasive breast cancer

@en

P1433

Q33967807-1B7A98A7-8108-466A-8086-F6DDD28385DF

P1476

Q33967807-9B0BD8EE-3742-4700-B7A6-D05717844083

P2093

Q33967807-036F36A5-72CC-4025-80B8-E00AD1F87ADB

Q33967807-471CE22D-F7E7-4E5B-9067-F5CE8F716B75

Q33967807-48F87BB6-53AA-41FF-904B-57CF24C137AB

Q33967807-7AD88967-2B1E-407E-A38E-F5F6BBDAC11B

Q33967807-7CFC3567-15E7-46F5-99A5-C00147B221C0

Q33967807-A044628C-A1CF-43B5-9088-4CA386297240

Q33967807-B1745EAB-AEE8-4959-A0DB-5B17E9687307

Q33967807-BE1C5471-2B71-4F55-8BA6-817ABF08228C

Q33967807-D59DD813-2BA4-460B-845D-4DEEBEF6FF65

Q33967807-F3CC7612-C7BD-46E7-9394-B7937F7CB3D8

P2860

Q33967807-03A480AD-2F5E-4AB8-AE30-345E8A5D5B02

Q33967807-03ABB191-2D95-4E0C-8E17-0E7C2DF423B9

Q33967807-06C1721A-AF8D-48B2-AEE0-36404148A551

Q33967807-10C46E4C-A150-4FF5-BF4E-58D07B87BDED

Q33967807-150F71F8-4305-44BE-99A5-B59A5E1BF6A5

Q33967807-299EECB4-C816-4496-A302-04D57D8D0C17

Q33967807-2FCED80F-DDB1-457A-9CC8-C57C3264EA04

Q33967807-31AA4ACE-6CA6-4FF4-9FAD-4B104CD9CA51

Q33967807-35BDB8C4-4AF0-415A-8D95-8479552057D0

Q33967807-365D876B-E008-4719-96AC-BFE72CCE5404

P304

Q33967807-5ACBDC97-5F5B-4682-98CF-28104056A49C

P31

Q33967807-A7733C04-205C-409A-99A3-4453ECCF153C

P356

Q33967807-2377AEE6-8AD7-4B9A-9038-AA9147E42BAE

P433

Q33967807-907C257E-8AC3-42DC-B761-DD54D932B452

P478

Q33967807-08DE8FD5-B161-48CD-A286-922D27E1A69C

P577

Q33967807-55D9E01E-FF3E-42F0-84A0-46EF1DCC7061

P5875

Q33967807-B1DDDE9D-F1C5-40C6-AB61-FB3346586C74

P698

Q33967807-B4DBA259-1FED-46F8-9163-54D0C294F6CB

P921

Q33967807-9CBA3A8E-2E04-4CE9-9AC7-2B1A66A041A9

P932

Q33967807-6D50D60C-0D69-4447-ADF9-B3073136FFF3

P356

P1433

Oncology Letters

P1476

miR-320a is an independent prognostic biomarker for invasive breast cancer

@en

P2093

Chengyu Chu

http://www.w3.org/2001/XMLSchema#string

DI Ding

http://www.w3.org/2001/XMLSchema#string

Haiping Yang

http://www.w3.org/2001/XMLSchema#string

Juan Yu

http://www.w3.org/2001/XMLSchema#string

Lei Wang

http://www.w3.org/2001/XMLSchema#string

Lei Zhang

http://www.w3.org/2001/XMLSchema#string

Qi Chen

http://www.w3.org/2001/XMLSchema#string

Qiang Zou

http://www.w3.org/2001/XMLSchema#string

Xiuping Liu

http://www.w3.org/2001/XMLSchema#string

Zude Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

microRNAs as oncogenes and tumor suppressors

MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis

MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival

Characterization of the small RNA transcriptomes of androgen dependent and independent prostate cancer cell line by deep sequencing.

miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.

Chemotherapy-induced modification of microRNA expression in esophageal cancer.

Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival.

MiR-27 as a prognostic marker for breast cancer progression and patient survival.

P304

1043-1050

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2014.2298

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264793238

http://www.w3.org/2001/XMLSchema#string

P698

25120655

http://www.w3.org/2001/XMLSchema#string

P921

P932

4114662

http://www.w3.org/2001/XMLSchema#string